TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
SABS

SAB Biotherapeutics Inc

Healthcare · Biotechnology

3.30$ -1.8% vs. previous close Closing price · As of: Sep 25, 2026

Ownership

Ownership Structure

Who owns SAB Biotherapeutics Inc (SABS)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 68.2% of the shares are freely tradable; institutional investors hold 81.2%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 81.2%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 0.7%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 68.2%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 4.7%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 91Mio.

Largest Shareholders

Institutions

Institutions SABS
Name Stake (%) Shares Change (%) Date
Caligan Partners LP 8.76 7,967,207 +0.0 06/30/2026
Vivo Capital, LLC 8.02 7,299,909 -36.1 06/30/2026
Perceptive Advisors LLC 7.28 6,627,501 +3.0 06/30/2026
Adage Capital Partners Gp LLC 7.04 6,405,553 +88.1 06/30/2026
COMMODORE CAPITAL LP 4.84 4,401,500 +0.0 03/31/2026
RA Capital Management, LLC 4.84 4,401,500 +0.0 03/31/2026
Balyasny Asset Management LLC 4.13 3,760,439 +690.9 03/31/2026
Woodline Partners LP 3.13 2,851,791 +0.0 03/31/2026
Millennium Management LLC 3.02 2,749,087 -9.4 06/30/2026
Vanguard Capital Management, LLC 2.74 2,493,737 +0.0 03/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings SABS
Person Role Shares Value As of Type
Kropotova Alexandra CHIEF MEDICAL OFFICER 41,853 138,115 $ Sep 17, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Sep 17, 2026 Kropotova Alexandra CHIEF MEDICAL OFFICER Other 473 – –

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?